Audentes Therapeutics, Inc. Increase (Decrease) in Restricted Cash for Operating Activities
Audentes Therapeutics, Inc. reported Increase (Decrease) in Restricted Cash for Operating Activities of -$56.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2018-03-09
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-12-31 was -$406.00K.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-09-30 was $0.00.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-03-31 was $350.00K.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for fiscal 2017 was -$56.00K, a 162.22% decline from fiscal 2016.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for fiscal 2016 was $90.00K, a 97.51% decline from fiscal 2015.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for fiscal 2015 was $3.61M.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 3 month | Increase (Decrease) in Restricted Cash for Operating Activities 6 month | Increase (Decrease) in Restricted Cash for Operating Activities 9 month | Increase (Decrease) in Restricted Cash for Operating Activities 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$406.00K derived: sum of 2 quarters · filed 2018-03-09 | -$406.00K derived: sum of 3 quarters · filed 2018-03-09 | -$56.00K 10-K · filed 2018-03-09 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $350.00K 10-Q · filed 2017-11-14 | -$72.00K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $350.00K 10-Q · filed 2017-08-10 | -$72.00K derived: sum of 3 quarters · filed 2018-03-09 | -$4.27M derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-03-31 | $350.00K 10-Q · filed 2017-05-11 | -$72.00K derived: sum of 2 quarters · filed 2018-03-09 | -$4.27M derived: sum of 3 quarters · filed 2018-03-09 | $440.00K derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-12-31 | -$422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$4.62M derived: sum of 2 quarters · filed 2018-03-09 | $90.00K derived: sum of 3 quarters · filed 2018-03-09 | $90.00K 10-K · filed 2018-03-09 |
| 2016-09-30 | -$4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $512.00K derived: sum of 2 quarters · filed 2017-11-14 | $512.00K 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $4.71M 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | $3.61M 10-K · filed 2018-03-09 |